MLL’s patent team successfully represented Swisscom Switzerland in a patent infringement claim of a non-practicing entity directed at Swisscom’s product “Swisscom TV 2.0”, in particular the technology that allows specific parts of programs to be selected and reviewed after the broadcast. The Swiss Federal Patent Court considered the patent of the NPE to be invalid […]
In preliminary injunction proceedings initiated by Lindt & Sprüngli, the Commercial Court of the Canton of Aargau prohibited the use of a copy of Lindt’s trademark protected “Pouring Shot” logo on the packaging
MLL represented the Lumimart division of Coop, the second biggest Swiss retailer, in a trademark / unfair competition case against the German company Luminarte. The litigation team was composed of MLL’s attorneys-at-law Michael Ritscher (Head
The litigation team was composed of MLL’s attorneys-at-law Michael Ritscher (Head of IP - pictured) and Kilian Schärli (partner) as well as European Patent Attorney Thorsten Bausch (partner at Hoffmann Eitle) and MLL’
Cocoa Luxury was represented by Simon Holzer (pictured), Renato Bucher and Anna Karczewski.
The MLL team was led by Simon Holzer (pictured) and Ulrike Ciesla.
Walder Wyss represented OTTO'S in this legal dispute. The team included Michael Isler (Partner, IP/IT - pictured) and Christine Leuch (Managing Associate, IP/IT).
The Swiss Federal Patent Court held that Alcon, by having made changes during examination to some claim features, had violated Art. 123 (2) EPC, and revoked the Swiss and Liechtenstein part of Alcon's European patent. The decision
Meyerlustenberger Lachenal (MLL) represented ImplanTec, a family owned company specialized in the development, manufacture and sale of artificial hip joint endoprostheses in patent infringement proceedings before the Federal Patent Court and in subsequent appeal proceedings
Walder Wyss’ IP team successfully represented the pharmaceutical company Merck in appeal proceedings before the Swiss Federal Supreme Court against its US competitor MSD. The case Following World War I, Merck’s US subsidiary, which